C4 Therapeutics (CCCC) Other Gross PP&E Adjustments (2019 - 2025)
C4 Therapeutics' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$38.7 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 27.62% year-over-year to -$38.7 million; the TTM value through Dec 2025 reached -$38.7 million, up 27.62%, while the annual FY2025 figure was -$38.7 million, 27.62% up from the prior year.
- Other Gross PP&E Adjustments reached -$38.7 million in Q4 2025 per CCCC's latest filing, down from -$26.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$3.1 million in Q3 2021 to a low of -$65.6 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$41.3 million, with a median of -$46.6 million recorded in 2024.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 51.19% in 2021, then plummeted 1735.26% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$25.6 million in 2021, then crashed by 137.88% to -$60.9 million in 2022, then increased by 4.54% to -$58.1 million in 2023, then rose by 8.02% to -$53.5 million in 2024, then increased by 27.62% to -$38.7 million in 2025.
- Per Business Quant, the three most recent readings for CCCC's Other Gross PP&E Adjustments are -$38.7 million (Q4 2025), -$26.4 million (Q3 2025), and -$38.7 million (Q2 2025).